IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.2010
+0.0150 (8.06%)
Aug 3, 2026, 12:06 PM CET
IntegraGen Revenue
In the year 2025, IntegraGen had annual revenue of 5.02M EUR, down -42.28%. IntegraGen had revenue of 2.46M in the half year ending December 31, 2025, a decrease of -61.90%.
Revenue
5.02M
Revenue Growth
-42.28%
P/S Ratio
0.24
Revenue / Employee
135.70K
Employees
37
Market Cap
1.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.02M | -3.68M | -42.28% |
| Dec 31, 2024 | 8.70M | -3.84M | -30.62% |
| Dec 31, 2023 | 12.54M | -629.33K | -4.78% |
| Dec 31, 2022 | 13.17M | 1.84M | 16.27% |
| Dec 31, 2021 | 11.32M | 2.34M | 26.11% |
| Dec 31, 2020 | 8.98M | 699.70K | 8.45% |
| Dec 31, 2019 | 8.28M | 1.36M | 19.62% |
| Dec 31, 2018 | 6.92M | 674.56K | 10.80% |
| Dec 31, 2017 | 6.25M | 225.04K | 3.74% |
| Dec 31, 2016 | 6.02M | 438.41K | 7.85% |
| Dec 31, 2015 | 5.58M | -451.61K | -7.48% |
| Dec 31, 2014 | 6.04M | 627.92K | 11.61% |
| Dec 31, 2013 | 5.41M | 666.66K | 14.06% |
| Dec 31, 2012 | 4.74M | 91.62K | 1.97% |
| Dec 31, 2011 | 4.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Poxel | 7.66M |
| Aelis Farma | 2.08M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Plant Advanced Technologies | 1.65M |
| Aton | 656.93K |
| GenSight Biologics | 652.00K |
| Neovacs | 199.27K |
| TME Pharma | 27.00K |